Cargando…
Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
BACKGROUND: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of ou...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222604/ https://www.ncbi.nlm.nih.gov/pubmed/24274463 http://dx.doi.org/10.1186/1471-2296-14-179 |
_version_ | 1782343064746983424 |
---|---|
author | Holtman, Gea A Leeuwen, Yvonne Lisman-van Kollen, Boudewijn J Escher, Johanna C Kindermann, Angelika Rheenen, Patrick F van Berger, Marjolein Y |
author_facet | Holtman, Gea A Leeuwen, Yvonne Lisman-van Kollen, Boudewijn J Escher, Johanna C Kindermann, Angelika Rheenen, Patrick F van Berger, Marjolein Y |
author_sort | Holtman, Gea A |
collection | PubMed |
description | BACKGROUND: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of our choices, using a quality assessment tool for diagnostic accuracy studies (QUADAS-2). DESIGN: The study investigates the diagnostic value of fecal calprotectin for detecting inflammatory bowel disease in children presenting with chronic gastrointestinal symptoms in primary care. It is a prospective cohort study including two cohorts of children: one cohort will be recruited in primary care and the other in secondary/tertiary care. Test results of fecal calprotectin will be compared to one of the two reference standards for inflammatory bowel disease: endoscopy with histopathological examination of mucosal biopsies or assessment of clinical symptoms at 1-year follow-up. DISCUSSION: According to QUADAS-2 the use of two reference standards and the recruitment of patients in two populations may cause differential verification bias and spectrum bias, respectively. The clinical relevance of this potential bias and methods to adjust for this are presented. This study illustrates the importance of awareness of the different kinds of bias that result from choices in the design phase of a diagnostic study in a low prevalence setting. This approach is exemplary for other diagnostic research in primary care. |
format | Online Article Text |
id | pubmed-4222604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42226042014-11-07 Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example Holtman, Gea A Leeuwen, Yvonne Lisman-van Kollen, Boudewijn J Escher, Johanna C Kindermann, Angelika Rheenen, Patrick F van Berger, Marjolein Y BMC Fam Pract Study Protocol BACKGROUND: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of our choices, using a quality assessment tool for diagnostic accuracy studies (QUADAS-2). DESIGN: The study investigates the diagnostic value of fecal calprotectin for detecting inflammatory bowel disease in children presenting with chronic gastrointestinal symptoms in primary care. It is a prospective cohort study including two cohorts of children: one cohort will be recruited in primary care and the other in secondary/tertiary care. Test results of fecal calprotectin will be compared to one of the two reference standards for inflammatory bowel disease: endoscopy with histopathological examination of mucosal biopsies or assessment of clinical symptoms at 1-year follow-up. DISCUSSION: According to QUADAS-2 the use of two reference standards and the recruitment of patients in two populations may cause differential verification bias and spectrum bias, respectively. The clinical relevance of this potential bias and methods to adjust for this are presented. This study illustrates the importance of awareness of the different kinds of bias that result from choices in the design phase of a diagnostic study in a low prevalence setting. This approach is exemplary for other diagnostic research in primary care. BioMed Central 2013-11-25 /pmc/articles/PMC4222604/ /pubmed/24274463 http://dx.doi.org/10.1186/1471-2296-14-179 Text en Copyright © 2013 Holtman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Holtman, Gea A Leeuwen, Yvonne Lisman-van Kollen, Boudewijn J Escher, Johanna C Kindermann, Angelika Rheenen, Patrick F van Berger, Marjolein Y Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
title | Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
title_full | Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
title_fullStr | Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
title_full_unstemmed | Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
title_short | Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
title_sort | challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222604/ https://www.ncbi.nlm.nih.gov/pubmed/24274463 http://dx.doi.org/10.1186/1471-2296-14-179 |
work_keys_str_mv | AT holtmangeaa challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample AT leeuwenyvonnelismanvan challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample AT kollenboudewijnj challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample AT escherjohannac challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample AT kindermannangelika challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample AT rheenenpatrickfvan challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample AT bergermarjoleiny challengesindiagnosticaccuracystudiesinprimarycarethefecalcalprotectinexample |